Position history for Focus Partners Wealth's holdings in ImmunityBio, Inc.
Focus Partners Wealth holds 53,958 shares of IBRX (ImmunityBio, Inc.), worth $106,837 as of 2025-Q4. This is a new position. IBRX represents 0.0% of Focus Partners Wealth's portfolio.
Current Value
$106,837
Current Shares
53,958
Total Value Change
$0
Total Shares Change
0
Other major holders of IBRX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
New |
| 53,958 |
- |
| $106,837 |
| 0.0% |
| $1.98 |
30 |